At 48 h, rfhSP-D treatment induced release of cytochrome c attained significance in culture supernatant of cancer cells (LNCaP, PC3) and tissue biopsies of prostate cancer when compared to PrEC (Figure 7D). Here, CYCS is linked to prostate carcinoma.